CERVICAL SCREENING: EARLY DETECTION
According to Cancer Research UK, 1 in 142 females in the UK will be diagnosed with cervical cancer in their lifetime, yet 99.8% of cervical cancer cases in the UK are preventable.
A
s pharmacists, we can help raise awareness, provide information, and support women in accessing this life-
saving screening service
In Scotland, recent changes to the cervical screening programme are paving the way for more effective prevention and early detection.
The introduction of Human Papillomavirus (HPV) testing as part of smear tests has brought a significant shift in how cervical health is monitored.
Traditionally, cervical screening involved testing collected samples for changes in cells that might indicate the presence of cancer. The focus now is on detecting the presence of the HPV virus, a common virus that can lead to various types of cancer, with 99% of cervical cancers attributed to HPV.
The underlying principle of cervical screening remains the same: identifying the potential risk of cervical cancer at an early stage. By checking for
the HPV virus, healthcare professionals can identify those who might be at risk and closely monitor their health and to ensure that appropriate measures are taken to prevent the development of cancer.
A notable advantage of this new testing method is its accuracy and reliability compared to the previous cell-based approach.
This change in approach brings reassurance to both healthcare providers and those undergoing screening. The focus on HPV offers a more targeted strategy for identifying potential health risks.
Scotland's commitment to the well-being of its population is evident in its approach to cervical screening. Routine cervical screening is offered to individuals who identify as women and have a cervix, living within Scotland and falling between the ages of 25 and 64 years.
The interval between screenings has also been revised, with routine tests offered every five
years. This schedule not only allows for comprehensive monitoring but also ensures that potential risks are identified early.
For those who have tested positive for HPV in previous screenings, more frequent monitoring might be recommended. This approach helps healthcare professionals track the virus's progression within the body and detect any changes in the cervix's cells.
It's important to note that the presence of cell changes does not equate to an immediate diagnosis of cervical cancer. Most of these changes will naturally regress or respond well to treatment.
The shift to HPV testing within smear tests in Scotland not only enhances accuracy but also empowers individuals to take charge of their health by staying up-to-date with routine screenings.
These changes provide continued improvements in the battle against cervical cancer, emphasizing early detection and timely intervention.
scottishpharmacist.com 21
CERVICAL SCREENING PLAYS A VITAL ROLE IN DETECTING EARLY SIGNS OF CERVICAL CANCER AND SAVING LIVES
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48
